New Data on Novogen Limited Oncology Pipeline to Be Released

SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - October 23, 2007) - New data on the Novogen oncology pipeline compound NV-128 will be presented on October 23 at the annual AACR/EORTC/NCI Molecular Targets and Cancer Therapeutics conference, to be held in San Francisco. The data will be presented by Gil Mor, MD, Associate Professor, Department of Obstetrics and Gynecology, Yale University School of Medicine. An abstract describing the presentation is available at http://www.aacr.org/home/scientists/meetings--workshops/molecular-targets-and-cancer-therapeutics/abstracts.aspx